December 16, 2019, Foster City, CA, Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced the...
MUSC Foundation for Research Development welcomes Art Pappas to board
News | 04. 23. 2014
Pappas to share venture capital expertise in pharmaceutical and life sciences industries
CHARLESTON, SC – April 23, 2014 – The Medical University of South Carolina Foundation for Research Development (FRD) has announced that venture capitalist Art Pappas has joined the organization’s Board of Directors, effective immediately.
